Advertisement
Screener

MUSTANG BIO, INC. (MBIO) Debt Instrument, Interest Rate, Stated Percentage

2.8 / 5 stars · 68/120 Roast Me

MUSTANG BIO, INC. Debt Instrument, Interest Rate, Stated Percentage

MUSTANG BIO, INC. (MBIO) had Debt Instrument, Interest Rate, Stated Percentage of 2.50% as of 2019-12-31, per its 10-K filed 2020-03-16.

Discontinued › Notes › Debt › Debt Instruments

us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2020-08-10

  • 2019-12-31: Debt Instrument, Interest Rate, Stated Percentage 2.50%.
  • 2019-09-30: Debt Instrument, Interest Rate, Stated Percentage 2.50%.
  • 2019-03-29: Debt Instrument, Interest Rate, Stated Percentage 9.00%; Debt Instrument, Interest Rate, Stated Percentage as first filed 2.50%.
Period endDebt Instrument, Interest Rate, Stated PercentageDebt Instrument, Interest Rate, Stated Percentage as first filed
2019-12-312.50%
10-K · filed 2020-03-16
2019-09-302.50%
10-Q · filed 2019-11-12
2019-03-299.00%
10-Q · filed 2020-08-10
2.50%
10-Q · filed 2019-05-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
BIOVIE INC. (BIVI)United States$0.012B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B